Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia.
acute myeloid leukemia
circadian rhythm
diet
time-restricted feeding
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
revised:
29
11
2023
received:
02
05
2023
accepted:
09
01
2024
medline:
9
2
2024
pubmed:
9
2
2024
entrez:
9
2
2024
Statut:
ppublish
Résumé
Acute myeloid leukemia (AML) with an internal tandem duplication in the fms-like tyrosine kinase receptor 3 gene (FLT3-ITD) is associated with poor survival, and few studies have examined the impact of modifiable behaviors, such as nutrient quality and timing, in this subset of acute leukemia. The influence of diet composition (low-sucrose and/or low-fat diets) and timing of diet were tested in tandem with anthracycline treatment in orthotopic xenograft mouse models. A pilot clinical study to test receptivity of pediatric leukemia patients to macronutrient matched foods was conducted. A role for the circadian protein, BMAL1 (brain and muscle ARNT-like 1), in effects of diet timing was studied by overexpression in FLT3-ITD-bearing AML cells. Reduced tumor burden in FLT3-ITD AML-bearing mice was observed with interventions utilizing low-sucrose and/or low-fat diets, or time-restricted feeding (TRF) compared to mice fed normal chow ad libitum. In a tasting study, macronutrient matched low-sucrose and low-fat meals were offered to pediatric acute leukemia patients who largely reported liking the meals. Expression of the circadian protein, BMAL1, was heightened with TRF and the low-sucrose diet. BMAL1 overexpression and treatment with a pharmacological inducer of BMAL1 was cytotoxic to FLT3-ITD AML cells. Mouse models for FLT3-ITD AML show that diet composition and timing slows progression of FLT3-ITD AML growth in vivo, potentially mediated by BMAL1. These interventions to enhance therapy efficacy show preliminary feasibility, as pediatric leukemia patients responded favorable to preparation of macronutrient matched meals.
Sections du résumé
BACKGROUND
BACKGROUND
Acute myeloid leukemia (AML) with an internal tandem duplication in the fms-like tyrosine kinase receptor 3 gene (FLT3-ITD) is associated with poor survival, and few studies have examined the impact of modifiable behaviors, such as nutrient quality and timing, in this subset of acute leukemia.
METHODS
METHODS
The influence of diet composition (low-sucrose and/or low-fat diets) and timing of diet were tested in tandem with anthracycline treatment in orthotopic xenograft mouse models. A pilot clinical study to test receptivity of pediatric leukemia patients to macronutrient matched foods was conducted. A role for the circadian protein, BMAL1 (brain and muscle ARNT-like 1), in effects of diet timing was studied by overexpression in FLT3-ITD-bearing AML cells.
RESULTS
RESULTS
Reduced tumor burden in FLT3-ITD AML-bearing mice was observed with interventions utilizing low-sucrose and/or low-fat diets, or time-restricted feeding (TRF) compared to mice fed normal chow ad libitum. In a tasting study, macronutrient matched low-sucrose and low-fat meals were offered to pediatric acute leukemia patients who largely reported liking the meals. Expression of the circadian protein, BMAL1, was heightened with TRF and the low-sucrose diet. BMAL1 overexpression and treatment with a pharmacological inducer of BMAL1 was cytotoxic to FLT3-ITD AML cells.
CONCLUSIONS
CONCLUSIONS
Mouse models for FLT3-ITD AML show that diet composition and timing slows progression of FLT3-ITD AML growth in vivo, potentially mediated by BMAL1. These interventions to enhance therapy efficacy show preliminary feasibility, as pediatric leukemia patients responded favorable to preparation of macronutrient matched meals.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e6949Subventions
Organisme : NIH HHS
ID : R21NR019532
Pays : United States
Organisme : NIH HHS
ID : P30 CA016672
Pays : United States
Informations de copyright
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Orgel E, Framson C, Buxton R, et al. Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial. Blood Adv. 2021;5(7):1853-1861. doi:10.1182/bloodadvances.2020004018
Hermetet F, Mshaik R, Simonet J, Callier P, Delva L, Quere R. High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells. Sci Rep. 2020;10(1):16187. doi:10.1038/s41598-020-73020-4
Yan F, Shen N, Pang JX, et al. Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells. Leukemia. 2017;31(6):1434-1442. doi:10.1038/leu.2016.349
Meshinchi S, Alonzo TA, Stirewalt DL, et al. Clinical implications of FLT3 mutations in pediatric AML. Blood. 2006;108(12):3654-3661. doi:10.1182/blood-2006-03-009233
Viani K, Trehan A, Manzoli B, Schoeman J. Assessment of nutritional status in children with cancer: a narrative review. Pediatr Blood Cancer. 2020;67(Suppl 3):e28211. doi:10.1002/pbc.28211
Liu J, Rehm CD, Onopa J, Mozaffarian D. Trends in diet quality among youth in the United States, 1999-2016. JAMA. 2020;323(12):1161-1174. doi:10.1001/jama.2020.0878
Puram RV, Kowalczyk MS, de Boer CG, et al. Core circadian clock genes regulate leukemia stem cells in AML. Cell. 2016;165(2):303-316. doi:10.1016/j.cell.2016.03.015
Li R, Raber M, Chandra J. Developing a healthy web-based cookbook for pediatric cancer patients and survivors: rationale and methods. JMIR Res Protoc. 2015;4(1):e37. doi:10.2196/resprot.3777
Shaw L, Nunns M, Briscoe S, Anderson R, Thompson Coon J. A "rapid best-fit" model for framework synthesis: using research objectives to structure analysis within a rapid review of qualitative evidence. Res Synth Methods. 2021;12(3):368-383. doi:10.1002/jrsm.1462
Doroshow JH, Synold TW, Somlo G, Akman SA, Gajewski E. Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin. Blood. 2001;97(9):2839-2845. doi:10.1182/blood.v97.9.2839
Nadin SB, Vargas-Roig LM, Cuello-Carrión FD, Ciocca DR. Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress Chaperones. 2003;8(4):361-372. doi:10.1379/1466-1268(2003)0082.0.co;2
Wartenberg L, Raber M, Chandra J. Unique features of a web-based nutrition website for childhood cancer populations: descriptive study. J Med Internet Res. 2021;23(9):e24515. doi:10.2196/24515
Kohsaka A, Laposky AD, Ramsey KM, et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab. 2007;6(5):414-421. doi:10.1016/j.cmet.2007.09.006
Froy O. The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol. 2007;28(2-3):61-71. doi:10.1016/j.yfrne.2007.03.001
Hatori M, Vollmers C, Zarrinpar A, et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012;15(6):848-860. doi:10.1016/j.cmet.2012.04.019
Chaix A, Zarrinpar A, Miu P, Panda S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014;20(6):991-1005. doi:10.1016/j.cmet.2014.11.001
He B, Nohara K, Park N, et al. The small molecule Nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab. 2016;23(4):610-621. doi:10.1016/j.cmet.2016.03.007
Lellupitiyage Don SS, Robertson KL, Lin HH, et al. Nobiletin affects circadian rhythms and oncogenic characteristics in a cell-dependent manner. PLoS One. 2020;15(7):e0236315. doi:10.1371/journal.pone.0236315
Zheng S, Wang W, Aldahdooh J, et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genom Proteom Bioinform. 2022;20(3):587-596. doi:10.1016/j.gpb.2022.01.004
Yadav B, Wennerberg K, Aittokallio T, Tang J. Searching for drug synergy in complex dose-response landscapes using an interaction potency model. Comput Struct Biotechnol J. 2015;13:504-513. doi:10.1016/j.csbj.2015.09.001
Kim EJ, Choi MR, Park H, et al. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res. 2011;13(4):R78. doi:10.1186/bcr2927
Jiang Y, Pan Y, Rhea PR, et al. A sucrose-enriched diet promotes tumorigenesis in mammary gland in part through the 12-lipoxygenase pathway. Cancer Res. 2016;76(1):24-29. doi:10.1158/0008-5472.CAN-14-3432
van Driel MS, van Neerven SM, Vermeulen L. High-fat diet impacts on tumor development in the gut. Trends Cancer. 2021;7(8):664-665. doi:10.1016/j.trecan.2021.06.005
Goncalves MD, Lu C, Tutnauer J, et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Science. 2019;363(6433):1345-1349. doi:10.1126/science.aat8515
Chen GL, Luo Y, Eriksson D, et al. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6. Oncotarget. 2016;7(18):26653-26669. doi:10.18632/oncotarget.8474
Cunningham A, Erdem A, Alshamleh I, et al. Dietary methionine starvation impairs acute myeloid leukemia progression. Blood. 2022;140(19):2037-2052. doi:10.1182/blood.2022017575
Walker WH, Kaper AL, Meléndez-Fernández OH, et al. Time-restricted feeding alters the efficiency of mammary tumor growth. Chronobiol Int. 2022;39(4):535-546. doi:10.1080/07420528.2021.2011306
Papagiannakopoulos T, Bauer MR, Davidson SM, et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 2016;24(2):324-331. doi:10.1016/j.cmet.2016.07.001
Battaglin F, Chan P, Pan Y, et al. Clocking cancer: the circadian clock as a target in cancer therapy. Oncogene. 2021;40(18):3187-3200. doi:10.1038/s41388-021-01778-6
Pomatto-Watson LCD, Bodogai M, Bosompra O, et al. Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition. Nat Commun. 2021;12(1):6201. doi:10.1038/s41467-021-26431-4
Das M, Ellies LG, Kumar D, et al. Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. Nat Commun. 2021;12(1):565. doi:10.1038/s41467-020-20743-7
Burchett JB, Knudsen-Clark AM, Altman BJ. MYC ran up the clock: the complex interplay between MYC and the molecular circadian clock in cancer. Int J Mol Sci. 2021;22(14):7761. doi:10.3390/ijms22147761
Astone M, Santoro MM. Time to fight: targeting the circadian clock molecular machinery in cancer therapy. Drug Discov Today. 2021;26(5):1164-1184. doi:10.1016/j.drudis.2021.01.023
Zeng ZL, Luo HY, Yang J, et al. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2014;20(4):1042-1052. doi:10.1158/1078-0432.CCR-13-0171
Dong Z, Zhang G, Qu M, et al. Targeting glioblastoma stem cells through disruption of the circadian clock. Cancer Discov. 2019;9(11):1556-1573. doi:10.1158/2159-8290.CD-19-0215